Electric glove trial hopes to give kids with One-Sided weakness a stronger grip
NCT ID NCT06536634
First seen Nov 20, 2025 · Last updated Jun 12, 2026 · Updated 35 times
Summary
This study tests whether adding a gentle electrical stimulation glove to standard therapy can improve hand and arm function in children aged 6-18 with hemiparesis (one-sided weakness). For 5 weeks, one group uses the glove at home for 30 minutes a day, 5 days a week, plus their usual therapy. The other group continues only their usual therapy. Researchers will measure changes in hand coordination and brain activity to see if the glove offers extra benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMIPARESIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Inselspital
RECRUITINGBern, 3010, Switzerland
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.